Dyadic Logo Current.jpg
Dyadic to Present Disruptive C1 Technology at World Vaccine Congress Europe Announcing Expansion of Influenza Pipeline with Enhanced Efficacy Potential
04 oct. 2022 08h45 HE | Dyadic International, Inc.
JUPITER, Fla., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Monoclonal Antibodies Market
Global Monoclonal Antibodies (mAbs) Market Analysis Report 2022: A Projected $494.53 Billion Market by 2030
30 sept. 2022 05h58 HE | Research and Markets
Dublin, Sept. 30, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies Market Size, Share & Trends Analysis Report by Source Type (Chimeric, Murine, Humanized, Human), by Production Type (In...
22157.jpg
Global Antibody Therapeutics Market Analysis Report 2022-2027 - Key Manufacturers are Striving to Reduce In-house Operations to Leverage the Capabilities of CDMOs
26 sept. 2022 04h38 HE | Research and Markets
Dublin, Sept. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service offers an...
Dyadic Logo Current.jpg
Dyadic to Present at Upcoming Industry and Investor Events in September
08 sept. 2022 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Global Monoclonal Antibodies (Mabs) Market
Monoclonal Antibodies (MAbS) Global Market Report 2022: Increasing Product Launches and Regulatory Support for the Treatment of Rare Diseases to Fuel Future Growth
31 août 2022 04h28 HE | Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies (MAbS) Global Market Report 2022: By Source, By Application, By End-User" report has been added to ResearchAndMarkets.com's...
22157.jpg
Microbiome Partnering Terms and Agreements Report 2022: The Leading & Most Active Microbiome Dealmakers Since 2010
18 août 2022 06h43 HE | Research and Markets
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Microbiome...
Future Market Insights.png
Antibodies Market is Forecast to Reach a Valuation of US$ 601.614 Billion by the end of 2031 | Future Market Insights, Inc. NEWARK, Del, Aug. 18, 2022 (GLOBE NEWSWIRE) -- According to Future Market Insights, a leading market research and competitive intelligence provider, the antibodies market will grow at a 21x pace in...
TIP_link_300x300.jpg
Intravenous Immunoglobulin Market Size Hit $18.67Bn, Globally, by 2028 Growing at 7.6% CAGR | Exclusive Report by The Insight Partners
17 août 2022 10h13 HE | The Insight Partners
New York, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type...
22157.jpg
Monoclonal Antibody Industry Deals & Agreements, 2015 to 2022 - Access to 1,000+ Monoclonal Antibodies Deal Records, and the Leading Deals by Value Since 2015
16 août 2022 07h53 HE | Research and Markets
Dublin, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2015 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global...
Dyadic Logo Current.jpg
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10 août 2022 16h00 HE | Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...